These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 30509364
1. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease. You SC, An MH, Yoon D, Ban GY, Yang PS, Yu HT, Park RW, Joung B. Heart Rhythm; 2018 Dec; 15(12):1825-1832. PubMed ID: 30509364 [Abstract] [Full Text] [Related]
2. Rate-control treatment and mortality in atrial fibrillation. Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA. Circulation; 2015 Oct 27; 132(17):1604-12. PubMed ID: 26384160 [Abstract] [Full Text] [Related]
5. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Fauchier L, Grimard C, Pierre B, Nonin E, Gorin L, Rauzy B, Cosnay P, Babuty D, Charbonnier B. Am J Cardiol; 2009 Jan 15; 103(2):248-54. PubMed ID: 19121446 [Abstract] [Full Text] [Related]
7. Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure - A Nationwide Cohort Study. Yu HT, Yang PS, Lee H, You SC, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B. Circ J; 2018 Feb 23; 82(3):652-658. PubMed ID: 29142156 [Abstract] [Full Text] [Related]
8. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, Schmitt S, Holmes TH, Frayne SM, Phibbs CS, Yang F, Hoang DD, Ho PM, Heidenreich PA. J Am Coll Cardiol; 2014 Aug 19; 64(7):660-8. PubMed ID: 25125296 [Abstract] [Full Text] [Related]
10. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure. Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Behlouli H, Pilote L. Am J Cardiol; 2014 Aug 01; 114(3):401-6. PubMed ID: 24950677 [Abstract] [Full Text] [Related]
11. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Ouyang AJ, Lv YN, Zhong HL, Wen JH, Wei XH, Peng HW, Zhou J, Liu LL. Am J Cardiol; 2015 Apr 01; 115(7):901-6. PubMed ID: 25660972 [Abstract] [Full Text] [Related]
13. Heart rate outcomes with concomitant parenteral calcium channel blockers and beta blockers in rapid atrial fibrillation or flutter. Alowais SA, Hayes BD, Wilcox SR, Le J, Koehl JL, Fuh L. Am J Emerg Med; 2021 Jun 01; 44():407-410. PubMed ID: 32448773 [Abstract] [Full Text] [Related]
15. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation. Pastori D, Farcomeni A, Bucci T, Cangemi R, Ciacci P, Vicario T, Violi F, Pignatelli P. Int J Cardiol; 2015 Feb 01; 180():1-5. PubMed ID: 25460369 [Abstract] [Full Text] [Related]
16. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study. Mulder BA, Van Veldhuisen DJ, Crijns HJ, Tijssen JG, Hillege HL, Alings M, Rienstra M, Van den Berg MP, Van Gelder IC, RACE II Investigators. Heart Rhythm; 2014 Sep 01; 11(9):1543-50. PubMed ID: 24924587 [Abstract] [Full Text] [Related]
17. Comparative persistence on β-blockers versus calcium channel blockers for ventricular rate control in nonelderly patients with atrial fibrillation. Desai VC, Kelton CM, Metzger AH, Cavanaugh TM, Guo JJ, Heaton PC. Ann Pharmacother; 2014 Dec 01; 48(12):1570-9. PubMed ID: 25280975 [Abstract] [Full Text] [Related]